Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free NAMSW Stock Alerts

NewAmsterdam Pharma (NAMSW) Competitors

NewAmsterdam Pharma logo
$14.49 -1.51 (-9.44%)
As of 08/5/2026 02:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NAMSW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy NewAmsterdam Pharma stock or one of its competitors? MarketBeat compares NewAmsterdam Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NewAmsterdam Pharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does NewAmsterdam Pharma compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than NewAmsterdam Pharma. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for NewAmsterdam Pharma. NewAmsterdam Pharma's average media sentiment score of 1.97 beat 60 Degrees Pharmaceuticals' score of 0.00 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NewAmsterdam Pharma
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Summary

NewAmsterdam Pharma beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. NewAmsterdam Pharma's average media sentiment score of 1.97 beat Alpha Tau Medical's score of 1.14 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NewAmsterdam Pharma
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

Summary

NewAmsterdam Pharma beats Alpha Tau Medical on 2 of the 2 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Apollomics?

Apollomics (NASDAQ:APLMW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for Apollomics. NewAmsterdam Pharma's average media sentiment score of 1.97 beat Apollomics' score of 0.00 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Apollomics Neutral
NewAmsterdam Pharma Very Positive

Summary

NewAmsterdam Pharma beats Apollomics on 3 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to BioVie?

NewAmsterdam Pharma (NASDAQ:NAMSW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for BioVie. NewAmsterdam Pharma's average media sentiment score of 1.97 beat BioVie's score of 0.00 indicating that NewAmsterdam Pharma is being referred to more favorably in the media.

Company Overall Sentiment
NewAmsterdam Pharma Very Positive
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
NewAmsterdam PharmaN/A N/A N/A
BioVie N/A N/A N/A

Summary

NewAmsterdam Pharma beats BioVie on 3 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 1 articles in the media. NewAmsterdam Pharma's average media sentiment score of 1.97 beat Cardio Diagnostics' score of 0.98 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardio Diagnostics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NewAmsterdam Pharma
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Summary

NewAmsterdam Pharma beats Cardio Diagnostics on 2 of the 2 factors compared between the two stocks.

Get NewAmsterdam Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAMSW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAMSW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAMSW vs. The Competition

Export
MetricNewAmsterdam PharmaBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.61B$6.95B$12.87B
Dividend YieldN/A3.77%2.59%9.94%
P/E RatioN/A8.32270.8225.30
Price / SalesN/A1,294.25600.1582.65
Price / CashN/A101.3771.8950.37
Price / BookN/A17.6413.006.13
Net IncomeN/A-$13.22M$3.46B$342.95M
7 Day Performance-13.06%4.45%3.39%3.19%
1 Month Performance-42.26%-4.89%-2.69%-1.98%
1 Year Performance107.00%56.58%75.98%21.11%

NewAmsterdam Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAMSW
NewAmsterdam Pharma
N/A$14.49
-9.4%		N/A+20.8%$0.00$22.57MN/A29
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-53.8%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.55
-14.1%		N/A+1,133.6%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
+10.0%		N/A-29.9%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.35
-14.4%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAMSW) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel